The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...
Biotechnology companies are developing novel obesity medicines to compete with blockbuster weight-loss drugs.
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback